Local Wound Infiltration With Liposomal Bupivacaine Decreases Post-Cesarean Pain Scores

Avni Gupta, Justin Williams, Rose A Maxwell, Marilyn Kindig

Research output: Contribution to conferencePosterpeer-review

Abstract

Surgical patients are routinely prescribed opioid analgesics that are strongly associated with drug overdose deaths. Liposomal bupivacaine is a long-acting local anesthetic that received FDA approval in 2011 for local surgical site infiltration to promote post-operative analgesia. This anesthetic has demonstrated an improvement in post-operative pain control in various surgical realms, indicating a decreased need for opiates and subsequently decreased risks. However, few studies have investigated its use at the time of cesarean delivery.

Original languageAmerican English
StatePublished - Apr 30 2021
Event2021 Boonshoft School of Medicine Medical Student Research Symposium Abstracts and Posters - Virtual
Duration: Apr 29 2021Apr 29 2021

Conference

Conference2021 Boonshoft School of Medicine Medical Student Research Symposium Abstracts and Posters
Period4/29/214/29/21

Disciplines

  • Medical Education
  • Obstetrics and Gynecology
  • Surgery

Cite this